AHB(SH:688639) Shanxi Securities·2025-05-09 07:08Investment Rating - The report assigns an "Accumulate-A" rating to the company, indicating a positive outlook with expected stock price appreciation [8]. Core Views - The company has shown significant improvement in Q1 performance, with new product promotions yielding positive results [1]. - Despite a competitive market leading to price declines in key products like valine, the company is advancing multiple projects as planned, maintaining growth in core product output and sales [6]. - The establishment of strategic partnerships and new product developments is expected to open new market opportunities [7]. Financial Performance Summary - For the year 2024, the company achieved revenue of 2.178 billion yuan, a year-on-year increase of 12.37%, but the net profit attributable to shareholders decreased by 57.80% to 190 million yuan [5]. - In Q1 2025, the company reported revenue of 687 million yuan, a year-on-year increase of 37.20%, with a net profit of 51 million yuan, reflecting a 40.98% decline year-on-year but a significant 160.36% increase quarter-on-quarter [5]. - The gross margin for 2024 was 24.92%, down 15.60 percentage points year-on-year, while the net margin was 8.47%, down 14.57 percentage points year-on-year [5]. Financial Projections - The company is projected to achieve revenues of 2.536 billion yuan, 2.905 billion yuan, and 3.285 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 16.4%, 14.6%, and 13.1% [8]. - The net profit attributable to shareholders is expected to grow to 266 million yuan, 397 million yuan, and 506 million yuan over the same period, with growth rates of 40.2%, 49.3%, and 27.6% [8]. - The report anticipates earnings per share (EPS) of 1.06 yuan, 1.59 yuan, and 2.03 yuan for 2025, 2026, and 2027, respectively, with corresponding price-to-earnings (P/E) ratios of 26.0, 17.4, and 13.6 [8].